First Page | Document Content | |
---|---|---|
Date: 2016-10-24 01:27:48 | Tumor response from Phase II study of combination treatment of intratumoral HF10, a replication - competent HSV-1 oncolytic virus, and ipilimumab in patients with stage IIIB, IIIC, or IV unresectable or metastatic melanoAdd to Reading ListSource URL: www.takara-bio.co.jpDownload Document from Source WebsiteFile Size: 325,90 KBShare Document on Facebook |